WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries

The Tracker / August 2026 / K260751

510(k) cleared

35 Helix Guidewire

Piraeus Medical, Inc. · Aug 27, 2026 · K260751

FDA cleared the 35 Helix Guidewire from Piraeus Medical, Inc. on Aug 27, 2026 under K260751, a traditional 510(k). The device falls under product code MOF, Guide, Wire, Catheter, Neurovasculature, regulated at 21 CFR 870.1330 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Mar 6, 2026. The decision came 174 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Piraeus Medical, Inc. in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K260751?

K260751 is the FDA 510(k) for 35 Helix Guidewire, submitted by Piraeus Medical, Inc.. FDA's decision date was Aug 27, 2026, under product code MOF (Guide, Wire, Catheter, Neurovasculature).

Who makes the 35 Helix Guidewire?

Piraeus Medical, Inc., based in Maple Grove, MN, is the applicant of record for K260751.

How long did the K260751 review take?

FDA received the submission on Mar 6, 2026 and issued its decision on Aug 27, 2026, 174 days later.

← All decisions in August 2026